Brief: Relay Therapeutics Q2 Net Income USD -70.375 Million
07/08/2025 21:06
Aug 07 (Reuters) - Relay Therapeutics Q2 operating expenses USD 77.524 million. Q2 basic EPS USD -0.41 Q2 operating income USD -76.847 million Q2 revenue USD 677 thousand Q2 EPS USD -0.41
Recent news on Relay Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Moderna, Kontoor Brands, Ralph Lauren
U.S. STOCKS ON THE MOVE- Intuit, Deere, Advance Auto Parts
U.S. STOCKS ON THE MOVE-Keysight Technologies, Relay Therapeutics, Ralph Lauren
Relay Therapeutics gains after $275 mln equity raise
Brief: Relay Therapeutics Announces Pricing Of Public Offering Of Common Stock